Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Posts Tagged: UK Bribery Act

SFO launches criminal probe of GSK

GlaxoSmith Kline PLC is under investigation by the UK Serious Fraud Office for possible criminal violations, the pharma said Tuesday.

In a two-sentence statement, UK-based GSK said it had been informed by the SFO of a formal criminal investigation into GSK’s commercial practices.… Continue Reading

A conversation with Mythili Raman

Mythili Raman, partner in Covington & Burling’s Washington, DC officeAfter 18 years at the Justice Department, and leading the criminal division during 2013 and 2014, Mythili Raman joined Covington & Burling’s white-collar crime and litigation practice in April. Continue Reading

Survey shows corporate commitment to anti-corruption programs

Dow Jones Risk & Compliance conducted an online survey in February, asking 383 compliance professionals around the world to evaluate their anti-corruption compliance programs and name their top risk concerns.

Eighty of the respondents were in North America, 145 in Western Europe, 119 in Asia-Pacific, and 39 in other countries.… Continue Reading

Who should be on your PEP list?

International laws vary as to which persons are of most interest to regulators in their anti-money laundering and bribery rules. This makes creating a list of politically exposed persons a difficult task — even if a critical one.… Continue Reading

GSK probes Iraq sales

British pharma GlaxoSmithKline said it is investigating allegations the company hired government-employed doctors and pharmacists in Iraq as paid sales reps for its products.

“We are investigating allegations of improper conduct in our Iraq business.… Continue Reading